Castleman Disease Treatment Market Overview
The Castleman Disease Treatment Market was valued at USD 600 million in 2024 and is projected to reach USD 1 billion by 2035, growing at a CAGR of 4.4%. Castleman disease is a rare lymphoproliferative disorder characterized by abnormal growth of lymph nodes, requiring specialized therapeutic interventions. The market encompasses monoclonal antibodies, corticosteroids, chemotherapy, interferon...
0 Comments 0 Shares 2 Views 0 Reviews